Acadia Pharmaceuticals (ACAD) PT Raised to $17 at Oppenheimer
Tweet
Share
E-mailGet Alerts ACAD Hot Sheet
Price: $29.01 --0%
Rating Summary:
17 Buy, 10 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 8 | New: 14
Rating Summary:
17 Buy, 10 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 8 | New: 14
Join SI Premium – FREE
Oppenheimer analyst Jay Olson raised the price target on Acadia Pharmaceuticals (NASDAQ: ACAD) to $17.00 (from $16.00) while maintaining a Perform rating.
You May Also Be Interested In
- Acadia Pharmaceuticals (ACAD) PT Raised to $49 at UBS
- Klepierre (LI:FP) (KLPEF) PT Raised to EUR42 at Berenberg
- Canaccord Reiterates Buy Rating on Acadia Pharmaceuticals (ACAD)
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
